News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Psychosocial impact associated with a multicancer early detection test (PATHFINDER)
Pathfinder Test/news-medical.net
Jan 19, 2025, 20:59

Psychosocial impact associated with a multicancer early detection test (PATHFINDER)

Ryan Nipp, Gastrointestinal oncologist and cancer outcomes researcher at OU Health Stephenson Cancer Center, shared an article by Lincoln Nadauld on LinkedIn:

“Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study.”

Psychosocial impact associated with a multicancer early detection test (PATHFINDER)

Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study.

Authors: Lincoln Nadauld, et al.

Psychosocial impact associated with a multicancer early detection test (PATHFINDER)

Ryan Nipp, gastrointestinal oncologist and cancer outcomes researcher at OU Health Stephenson Cancer Center. His research platform consists of studies interfacing between palliative care, geriatric oncology and health services research. He completed an internal medicine residency at Duke University and oncology fellowship at Dana-Farber/Harvard Cancer Center.

cancer fight against cancer Global fight against cancer Lincoln Nadauld OncoDaily Oncology OU Health Stephenson Cancer Center PATHFINDER Ryan Nipp
Special Coverage
Science
Jan 19, 2025, 20:59
Psychosocial impact associated with a multicancer early detection test (PATHFINDER)
Blog
Jan 19, 2025, 15:36
Paolo Tarantino: How do you plan to use Datopotamab Deruxtecan for HR+/HER2- MBC?
Science
Jan 19, 2025, 15:26
Andrea Necchi: Thromboembolic and Cardiovascular Adverse Events with PARP Inhibitor Treatment in Patients with mCRPC
Insight
Jan 19, 2025, 15:23
Aleix Prat: Excited to share the results of the SOLTI-ELIPSE trial
Blog
Jan 19, 2025, 15:20
Danish Melanoma Lifetime Achievement Award to Lars Bastholt - Danish Metastatic Melanoma Database
Blog
Jan 19, 2025, 15:16
Caroline N. Smith: Hiring for an Assistant Director, Foundation and Scientific Partnerships at the V Foundation for Cancer Research
Blog
Jan 19, 2025, 15:12
Narjust Florez on the challenges and overwhelming sense of not belonging as a Latina in Medicine
Blog
Jan 19, 2025, 15:11
Monica Bertagnolli: It has been a privilege to serve as Director of NIH under President Joe Biden
Blog
Jan 19, 2025, 15:08
Cathy Eng: Speaking about the rising incidence of early-onset colorectal cancer at Tamron Hall Show
Blog
Jan 19, 2025, 15:04
Pam Mangat-Dhaliwal: How ASCO is putting its commitment to patient advocacy into action
Blog
Jan 19, 2025, 14:53
Dégi László Csaba: Thrilled to announce that I’ll be in Davos for the World Economic Forum
Insight
Jan 19, 2025, 14:52
Aleix Prat: The Katherine phase III updated results are out